Literature DB >> 10514011

Junctional amino acids determine the maturation pathway of an antibody.

K Furukawa1, A Akasako-Furukawa, H Shirai, H Nakamura, T Azuma.   

Abstract

We found that two distinct antibody maturation pathways exist in the immune response of C57BL/6 mice to (4-hydroxy-3-nitrophenyl)acetyl and that the junctional amino acid introduced by a process far preceding somatic hypermutation determined the pathway of affinity maturation. Antibodies belonging to each pathway clearly separated into two separate branches of a phylogenic tree. We also constructed a three-dimensional fitness landscape for antibody evolution by introducing the association constants of the antibodies into the phylogenic tree as the third axis, allowing us to comprehend the significance of junctional diversity in the "evolvability" of antibodies. Thermodynamic analyses of the antigen-antibody interactions suggested that a high conformational versatility in the antigen-combining site allows for the enhanced evolvability of antibodies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10514011     DOI: 10.1016/s1074-7613(00)80108-9

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  44 in total

1.  In vitro evolution of a T cell receptor with high affinity for peptide/MHC.

Authors:  P D Holler; P O Holman; E V Shusta; S O'Herrin; K D Wittrup; D M Kranz
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

2.  Dual beneficial effect of interloop disulfide bond for single domain antibody fragments.

Authors:  Jochen Govaert; Mireille Pellis; Nick Deschacht; Cécile Vincke; Katja Conrath; Serge Muyldermans; Dirk Saerens
Journal:  J Biol Chem       Date:  2011-11-29       Impact factor: 5.157

3.  Critical contribution of VH-VL interaction to reshaping of an antibody: the case of humanization of anti-lysozyme antibody, HyHEL-10.

Authors:  Takeshi Nakanishi; Kouhei Tsumoto; Akiko Yokota; Hidemasa Kondo; Izumi Kumagai
Journal:  Protein Sci       Date:  2008-02       Impact factor: 6.725

Review 4.  Germinal-center organization and cellular dynamics.

Authors:  Christopher D C Allen; Takaharu Okada; Jason G Cyster
Journal:  Immunity       Date:  2007-08       Impact factor: 31.745

5.  Both mutated and unmutated memory B cells accumulate mutations in the course of the secondary response and develop a new antibody repertoire optimally adapted to the secondary stimulus.

Authors:  Tomohiro Kaji; Koji Furukawa; Akiko Ishige; Itsumi Toyokura; Masaki Nomura; Mariko Okada; Yoshimasa Takahashi; Michiko Shimoda; Toshitada Takemori
Journal:  Int Immunol       Date:  2013-09-10       Impact factor: 4.823

6.  Directed evolution of a picomolar-affinity, high-specificity antibody targeting phosphorylated tau.

Authors:  Dan Li; Lei Wang; Brandon F Maziuk; Xudong Yao; Benjamin Wolozin; Yong Ku Cho
Journal:  J Biol Chem       Date:  2018-06-13       Impact factor: 5.157

7.  Correlated flexible molecular coding and molecular evolvability.

Authors:  Y Husimi; T Aita; I Tabuchi
Journal:  J Biol Phys       Date:  2002-09       Impact factor: 1.365

8.  Regulated selection of germinal-center cells into the memory B cell compartment.

Authors:  Ryo Shinnakasu; Takeshi Inoue; Kohei Kometani; Saya Moriyama; Yu Adachi; Manabu Nakayama; Yoshimasa Takahashi; Hidehiro Fukuyama; Takaharu Okada; Tomohiro Kurosaki
Journal:  Nat Immunol       Date:  2016-05-09       Impact factor: 25.606

9.  DNA polymerase theta contributes to the generation of C/G mutations during somatic hypermutation of Ig genes.

Authors:  Keiji Masuda; Rika Ouchida; Arata Takeuchi; Takashi Saito; Haruhiko Koseki; Kiyoko Kawamura; Masatoshi Tagawa; Takeshi Tokuhisa; Takachika Azuma; Jiyang O-Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-19       Impact factor: 11.205

10.  MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase.

Authors:  Grace Teng; Paul Hakimpour; Pablo Landgraf; Amanda Rice; Thomas Tuschl; Rafael Casellas; F Nina Papavasiliou
Journal:  Immunity       Date:  2008-05-01       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.